On September 23, 2024, Novo Nordisk A/S reported on its share repurchase program initiated on August 7, 2024, intending to buy back up to DKK 20 billion in shares over 12 months, with DKK 10.99 billion already spent since February 6, 2024, purchasing 12,465,249 B shares at an average price of DKK 881.62 per share.